scispace - formally typeset
A

Alison H. Trainer

Researcher at Peter MacCallum Cancer Centre

Publications -  109
Citations -  3577

Alison H. Trainer is an academic researcher from Peter MacCallum Cancer Centre. The author has contributed to research in topics: Breast cancer & Genetic testing. The author has an hindex of 28, co-authored 101 publications receiving 2799 citations. Previous affiliations of Alison H. Trainer include Centre for Life & Newcastle University.

Papers
More filters
Journal ArticleDOI

Clinical studies on submicroscopic subtelomeric rearrangements: a checklist.

TL;DR: The results suggest that good indicators for subtelomeric defects are prenatal onset of growth retardation and a positive family history for mental retardation, which will improve the diagnostic pick up rate of subtelomere defects among mentally retarded subjects.
Journal ArticleDOI

Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.

TL;DR: Inactivation of cell cycle checkpoints responsive to mitotic spindle disruption, by mutant forms of p53 or Bub1, relieves growth arrest and initiates neoplastic transformation in primary cells homozygous for truncated Brca2.
Journal ArticleDOI

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Xin Yang, +130 more
TL;DR: PALB2 is confirmed as a major breast cancer susceptibility gene and substantial associations between germline PALB2 PVs and ovarian, pancreatic, and male breast cancers are established.
Journal ArticleDOI

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Timothy R. Rebbeck, +248 more
- 01 May 2018 - 
TL;DR: In addition to known founder mutations, mutations of relatively high frequency were identified in specific racial/ethnic or geographic groups that may reflect founder mutations and which could be used in targeted (panel) first pass genotyping for specific populations.
Journal ArticleDOI

Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.

TL;DR: The data demonstrate the utility of intra-family exome-sequencing approaches to uncover cancer predisposing genes, but highlight the major challenge of definitively validating candidates where the incidence of sporadic disease is high, germline mutations are not fully penetrant, and individual predisposition genes may only account for a tiny proportion of breast cancer families.